Cargando…

The anti-tumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancer

Hematogenous metastasis, mainly hepatic metastasis, is a frequent metastatic mode in colorectal cancer involving angiogenic growth factors. Two angiogenic growth factors, in particular, Vascular endothelial growth factor (VEGF) and Prokineticin1(PROK1), are considered to have an important role in he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goi, Takanori, Nakazawa, Toshiyuki, Hirono, Yasuo, Yamaguchi, Akio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467421/ https://www.ncbi.nlm.nih.gov/pubmed/25788276

Ejemplares similares

The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1(No correlation coefficient between VEGF and PROK1)
por: Goi, Takanori, et al.
Publicado: (2015)

Prokineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer
por: Kurebayashi, Hidetaka, et al.
Publicado: (2015)

Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer
por: Goi, Takanori, et al.
Publicado: (2015)

CD44variant exon 9 plays an important role in colon cancer initiating cells
por: Kimura, Youhei, et al.
Publicado: (2013)

Polysaccharide K suppresses angiogenesis in colon cancer cells
por: SATOH, YOSHIKI, et al.
Publicado: (2012)

PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway
por: Fujimoto, Daisuke, et al.
Publicado: (2015)

The Multiple Roles of EG-VEGF/PROK1 in Normal and Pathological Placental Angiogenesis
por: Alfaidy, Nadia, et al.
Publicado: (2014)

Prokineticin-1 induces normal lymphangiogenic activity and is involved in lymphangiogenesis and lymph node metastasis in colorectal cancer
por: Naruse, Takayuki, et al.
Publicado: (2021)

Prokineticin 2 expression as a novel prognostic biomarker for human colorectal cancer
por: Yoshida, Yu, et al.
Publicado: (2018)

The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion
por: Fujimoto, Daisuke, et al.
Publicado: (2010)

MUC2 protein expression status is useful in assessing the effects of hyperthermic intraperitoneal chemotherapy for peritoneal dissemination of colon cancer
por: FUJISHIMA, YUKA, et al.
Publicado: (2012)

RPN2 is effective biomarker to predict the outcome of combined chemotherapy docetaxel and cisplatin for advanced gastric cancer
por: Fujimoto, Daisuke, et al.
Publicado: (2018)

Prokineticin 2/PROK2 and Male Infertility
por: Petrella, Carla, et al.
Publicado: (2022)

PROK2/PROKR2 Signaling and Kallmann Syndrome
por: Dodé, Catherine, et al.
Publicado: (2013)

ProkSeq for complete analysis of RNA-Seq data from prokaryotes
por: Mahmud, A K M Firoj, et al.
Publicado: (2020)

Large-scale quality assessment of prokaryotic genomes with metashot/prok-quality
por: Albanese, Davide, et al.
Publicado: (2021)

Five-Year Survival of Alpha-Fetoprotein-Producing Gastric Cancer with Synchronous Liver Metastasis: A Case Report
por: Koneri, Kenji, et al.
Publicado: (2013)

Silencing PROK2 Inhibits Invasion of Human Cervical Cancer Cells by Targeting MMP15 Expression
por: Wu, Min-Hua, et al.
Publicado: (2020)

Variations in PROKR2, But Not PROK2, Are Associated With Hypopituitarism and Septo-optic Dysplasia
por: McCabe, Mark J., et al.
Publicado: (2013)

A report of amelanotic malignant melanoma of the esophagus diagnosed appropriately with novel markers: A case report
por: Kobayashi, Junya, et al.
Publicado: (2018)

Expression of CD44 Variant Exons 8–10 in Colorectal Cancer and Its Relationship to Metastasis
por: Takeuchi, Kazuo, et al.
Publicado: (1995)

Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer
por: Goi, Takanori, et al.
Publicado: (2015)

PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer
por: Wang, Feng, et al.
Publicado: (2023)

ProkEvo: an automated, reproducible, and scalable framework for high-throughput bacterial population genomics analyses
por: Pavlovikj, Natasha, et al.
Publicado: (2021)

Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology
por: Lattanzi, Roberta, et al.
Publicado: (2019)

Dual EGFR inhibition in combination with anti-VEGF treatment in colorectal cancer
por: Falchook, Gerald S., et al.
Publicado: (2014)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

Osteoglycin-induced VEGF Inhibition Enhances T Lymphocytes Infiltrating in Colorectal Cancer
por: Hu, Xiang, et al.
Publicado: (2018)

Partial response after transcatheter arterial infusion chemotherapy in a patient with systemic chemotherapy-resistant unresectable colon cancer and hepatic metastasis: (case report)
por: Sawai, Katsuji, et al.
Publicado: (2013)

Large-cell neuroendocrine carcinoma of the common bile duct: a case report and a review of literature
por: Murakami, Makoto, et al.
Publicado: (2016)

A typical case of resected pancreatic hamartoma: a case report and literature review on imaging and pathology
por: Katayama, Hokahiro, et al.
Publicado: (2020)

Alzheimer's disease-associated inflammatory pathways might contribute to osteoporosis through the interaction between PROK2 and CSF3
por: Zhang, Wenzheng, et al.
Publicado: (2022)

FRI272 Sex-Specific Role Of ProkR2 Neurons Of The Posterior Amygdala In The Integration Of Odors And Neuroendocrine Responses
por: Cisneros-Larios, Brenda, et al.
Publicado: (2023)

Intrapleural targeted therapies (anti-VEGF and anti-EGFR) in the model of malignant pleural effusion
por: Acencio, Milena Marques Pagliarelli, et al.
Publicado: (2017)

Simultaneous Detection of EGFR and VEGF in Colorectal Cancer using Fluorescence-Raman Endoscopy
por: Kim, Yong-il, et al.
Publicado: (2017)

Antibody Targeting of Cathepsin S Inhibits Angiogenesis and Synergistically Enhances Anti-VEGF
por: Ward, Claire, et al.
Publicado: (2010)

The Association of Alternate VEGF Ligands with Resistance to Anti-VEGF Therapy in Metastatic Colorectal Cancer
por: Lieu, Christopher H., et al.
Publicado: (2013)

CTGF expression is up-regulated by PROK1 in early pregnancy and influences HTR-8/Svneo cell adhesion and network formation
por: Waddell, Jennifer M., et al.
Publicado: (2011)

Identification of PROK2 gene polymorphisms as predictors of methamphetamine use disorder risk and indicators of craving scale in the Chinese Han population
por: Jiang, Zhao, et al.
Publicado: (2023)

Response to Modified TEGAFIRI in a Patient with Synchronous Multiple Liver Metastases of Colon Cancer
por: Takanori, Goi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_n1e4e1ugrnstfjla8cjs7qsb1e